Camp4 Therapeutics Income Statement (2023-2026) | CAMP

Income Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 0.35M0.65M0.86M1.50M0.80M0.35M1.29M
Operating items
Research & Development (Quarter) 9.82M10.66M9.74M9.39M9.70M10.00M10.15M10.34M9.36M-29.64M10.16M
Selling, General & Administrative (Quarter) 2.87M2.81M3.13M3.27M3.81M4.69M3.81M4.18M4.60M-12.49M4.21M
Other Operating Expenses (Quarter) 0.49M55.26M
Operating Expenses (Quarter) 12.69M13.48M12.88M12.66M13.52M14.69M13.96M14.53M14.45M13.12M14.37M
Operating Income (Quarter) -12.34M-13.48M-12.88M-12.66M-13.52M-14.03M-13.10M-13.03M-13.65M-12.78M-13.07M
EBIT (Quarter) -12.34M-13.48M-12.88M-12.66M-13.52M-14.03M-13.10M-13.03M-13.65M-12.78M-13.07M
Non-operating items
Non Operating Investment Income (Quarter) -1.80M-28.03M-6.19M
Interest & Investment Income (Quarter) 0.69M0.57M0.40M0.23M0.09M0.61M0.59M0.45M0.42M0.71M0.91M
Other Non Operating Income (Quarter) 0.03M-0.14M-0.06M0.08M-0.01M-0.07M0.02M
Non Operating Income (Quarter) 0.64M0.49M0.03M-0.14M0.03M1.48M0.67M0.44M-1.45M-27.84M0.02M
Net income details
EBT (Quarter) -11.70M-12.99M-12.48M-12.43M-13.48M-13.28M-12.51M-12.57M-13.23M-12.07M-12.16M
Profit After Tax (Quarter) -11.70M-12.99M-12.46M-12.57M-13.48M-13.28M-12.43M-12.59M-15.10M-40.30M-18.33M
Income from Continuing Operations (Quarter) -11.70M-12.99M-12.48M-12.43M-13.48M-13.28M-12.51M-12.57M-13.23M-12.07M-12.16M
Consolidated Net Income (Quarter) -11.70M-12.99M-12.48M-12.43M-13.48M-13.28M-12.51M-12.57M-13.23M-12.07M-12.16M
Income towards Parent Company (Quarter) -11.70M-12.99M-12.48M-12.43M-13.48M-13.28M-12.51M-12.57M-13.23M-12.07M-12.16M
Net Income towards Common Stockholders (Quarter) -11.70M-12.99M-12.48M-12.43M-13.48M-13.28M-12.51M-12.57M-13.23M-12.07M-12.16M
Additional items
EPS (Basic) (Quarter) -29.21-30.18-26.57-26.00-24.1965.46-0.62-0.62-0.55-0.87-0.32
EPS (Weighted Average and Diluted) (Quarter) -29.21-30.18-26.57-26.00-24.1965.46-0.62-0.62-0.55-0.87-0.32
Shares Outstanding (Weighted Average) (Quarter) 0.40M0.39M0.47M0.48M0.50M4.69M20.15M20.16M27.27M30.38M57.92M
Shares Outstanding (Diluted Average) (Quarter) 0.38M0.39M0.47M0.48M0.50M4.69M20.15M20.16M27.27M30.38M57.92M
EBITDA (Quarter) -11.70M-12.99M-12.45M-12.58M-13.48M-13.28M-12.43M-12.59M-15.10M-40.28M-18.33M
Interest Expenses (Quarter) 0.05M0.08M0.06M-0.14M
Shares Outstanding (Quarter) 0.41M0.46M0.48M0.49M1.01M20.15M20.16M20.16M46.88M51.90M51.93M